Literature DB >> 1414495

The calcium oxalate crystal growth inhibitor protein produced by mouse kidney cortical cells in culture is osteopontin.

E M Worcester1, S S Blumenthal, A M Beshensky, D L Lewand.   

Abstract

Urine contains proteins that inhibit the growth of calcium oxalate (CaOx) crystals and may prevent the formation of kidney stones. We have identified a potent crystal growth inhibitor in the conditioned media from primary cultures of mouse kidney cortical cells. Conditioned media, incubated with the kidney cells for 6-72 h, was assayed for crystal growth inhibition; inhibitory activity increased 15-fold by 24 h. Inhibitory activity was purified from serum-free media containing proteinase inhibitors using anion-exchange and gel-filtration chromatography. A single band of molecular weight 80,000 daltons was seen after SDS-polyacrylamide gel electrophoresis. The sequence of the N-terminal 21 amino acids of this protein matched that of osteopontin (OP), a phosphoprotein initially isolated from bone matrix. Antisera raised to fusion proteins produced by plasmids containing the N-terminal or C-terminal portions of OP cDNA also cross-reacted with the protein purified from cell culture media on western blots. The effect of the purified protein on the growth of CaOx crystals was measured using a constant composition assay. A 50% inhibition of growth occurred at a protein concentration of 0.85 micrograms/ml, and the dissociation constant of the protein with respect to CaOx crystal was 3.7 x 10(-8) M. The concentration of OP in mouse urine, measured using antibodies raised to the purified protein, was approximately 8 micrograms/ml. We conclude that OP is synthesized by kidney cortical tubule cells and functions as a crystal growth inhibitory protein in urine.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1414495     DOI: 10.1002/jbmr.5650070905

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  21 in total

Review 1.  In vitro calcium oxalate crystallisation methods.

Authors:  John P Kavanagh
Journal:  Urol Res       Date:  2006-01-14

Review 2.  Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation.

Authors:  R L Ryall
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

3.  Association of urinary macromolecules with calcium oxalate crystals induced in vitro in normal human and rat urine.

Authors:  F Atmani; F J Opalko; S R Khan
Journal:  Urol Res       Date:  1996

Review 4.  Glycosaminoglycans, proteins, and stone formation: adult themes and child's play.

Authors:  R L Ryall
Journal:  Pediatr Nephrol       Date:  1996-10       Impact factor: 3.714

5.  Acidic polyanion poly(acrylic acid) prevents calcium oxalate crystal deposition.

Authors:  Jack G Kleinman; Laura J Alatalo; Ann M Beshensky; Jeffrey A Wesson
Journal:  Kidney Int       Date:  2008-06-18       Impact factor: 10.612

6.  Roles of electrostatics and conformation in protein-crystal interactions.

Authors:  Paul V Azzopardi; Jason O'Young; Gilles Lajoie; Mikko Karttunen; Harvey A Goldberg; Graeme K Hunter
Journal:  PLoS One       Date:  2010-02-19       Impact factor: 3.240

7.  The effect of warfarin on urine calcium oxalate crystal growth inhibition and urinary excretion of calcium and nephrocalcin.

Authors:  E M Worcester; J L Sebastian; J G Hiatt; A M Beshensky; J A Sadowski
Journal:  Calcif Tissue Int       Date:  1993-10       Impact factor: 4.333

8.  Specific adsorption of osteopontin and synthetic polypeptides to calcium oxalate monohydrate crystals.

Authors:  Adam Taller; Bernd Grohe; Kem A Rogers; Harvey A Goldberg; Graeme K Hunter
Journal:  Biophys J       Date:  2007-05-11       Impact factor: 4.033

9.  Macrophages express osteopontin during repair of myocardial necrosis.

Authors:  C E Murry; C M Giachelli; S M Schwartz; R Vracko
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

10.  Identification of a macromolecular crystal growth inhibitor in human urine as osteopontin.

Authors:  S Sørensen; S J Justesen; A H Johnsen
Journal:  Urol Res       Date:  1995
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.